-39.8%
COIN vs MRNA
+511.3%
-551.1%
-63.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.2% | -2.2% | -2.0% | -4.0% |
| 7D | +3.4% | +5.5% | -2.1% | +2.8% |
| 30D | +23.2% | +158.7% | -135.5% | +1.0% |
| 3M | +12.5% | +182.1% | -169.6% | -11.8% |
| 6M | -11.6% | +151.8% | -163.4% | -28.4% |
| YTD | -18.4% | +393.6% | -411.9% | -45.4% |
| 1Y | -39.8% | +499.5% | -539.3% | -61.5% |
| All | -39.8% | +511.3% | -551.1% | -61.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling